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Abstract Human bone marrow mesenchymal stem
cells (HBMSCs) has been the gold standard for bone
regeneration. However, the low proliferation rate and
long doubling time limited its clinical applications.
This study aims to compare the bone tissue engineer-
ing efficacy of human dental pulp stem cells
(HDPSCs) with HBMSCs in 2D, and 3D anorganic
bone mineral (ABM) coated with a biomimetic
collagen peptide (ABM-P-15) for improving bone-
forming speed and efficacy in vitro and in vivo. The
multipotential of both HDPSCs and HBMSCs have
been compared in vitro. The bone formation of
HDPSCs on ABM-P-15 was tested using in vivo
model. The osteogenic potential of the cells was
confirmed by alkaline phosphatase (ALP) and
immunohistological staining for osteogenic markers.
Enhanced ALP, collagen, lipid droplet, or
glycosaminoglycans production were visible in
HDPSCs and HBMSCs after osteogenic, adipogenic
and chondrogenic induction. HDPSC showed stronger
ALP staining compared to HBMSCs. Confocal images
showed more viable HDPSCs on both ABM-P-15 and
ABM scaffolds compared to HBMSCs on similar
scaffolds. ABM-P-15 enhanced cell attachment/
spreading/bridging formation on ABM-P-15 scaffolds
and significantly increased quantitative ALP specific
activities of the HDPSCs and HBMSCs. After 8 weeks
in vivo implantation in diffusion chamber model, the
HDPSCs on ABM-P-15 scaffolds showed extensive
high organised collagenous matrix formation that was
positive for COL-I and OCN compared to ABM alone.
In conclusion, the HDPSCs have a higher proliferation
rate and better osteogenic capacity, which indicated
the potential of combining HDPSCs with ABM-P-15
scaffolds for improving bone regeneration speed and
efficacy.
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Introduction
The increasing clinical demand for bone regeneration
and repair in the context of our ageing population
poses a challenge both to healthcare providers and
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society (Iaquinta et al. 2019). There is also increasing
demand for the implant osseointegration, which is
crucial for successful implantology in both orthopae-
dics and dentistry (Chandran and John 2019; Liu et al.
2019). Tissue engineering provides a promising strat-
egy to meet this clinical demand by developing
functional bone construct using stem/stromal cells,
biomimetic biomaterial scaffolds, with/without
growth factors (Abdulghani and Mitchell 2019).
However, the main challenge is to identify the most
appropriate combination of the three elements that can
be used to achieve optimum regeneration of damaged
bone tissue (Panetta et al. 2009).
Under in vitro conditions, mesenchymal stem cells
(MSCs) exhibit the ability to form fibroblastic
colonies on tissue culture plastic (Gothard et al.
2013) and can differentiate alone osteoblast, chondro-
cyte, adipocytes, and other different lineages when
cultured under the appreciate inductive media (Garcia-
Sanchez et al. 2019). HBMSCs has been considered as
one of the most popular stem cell sources for stem cells
therapy and bone tissue engineering (Connolly et al.
1989; Kern et al. 2006; Squillaro et al. 2016; Yoshii
et al. 2009). However, bone marrow biopsy/aspiration
itself is an invasive procedure, and in elderly patients,
they often lack good quality and quantity of desired
stem cells within the bone marrow (Yamada et al.
2014). It has been documented that the poor response
of these cells is due to the loss of potential to
proliferate and differentiate with increasing donor age
(Jones and Schafer 2015; Kern et al. 2006; Muschler
et al. 2001; Yamada et al. 2010; Yoshii et al. 2009).
Taken together, these factors have led to the search for
an alternative adult stem cell sources which can be
easily accessed with minimal invasion and provide the
stem cells with similar or better regenerative potential
as HBMSCs. In nature, every individual, during their
lifetime, experiences teeth loss (80% of subjects had
lost one or more tooth, and the mean tooth loss was
5.09)(Ribeiro et al. 2015), which provides an oppor-
tunity to access dental tissues with minimal invasion
making the option of isolating of stem cells from
dental pulp a promising alternative source to
HBMSCs. Pulp tissues can be obtained from either
permanent or deciduous teeth, however, wisdom teeth
(third molars) have long been a preferred choice of the
permanent teeth (Ledesma-Martinez et al. 2016). This
may due to the third molars are routinely extracted due
to impaction caused by the lack of jaw space, and it is
also the last permanent teeth to erupt, and their pulp
tissue is considered to be rich in unspecialised cells
(Gronthos et al. 2000; Ledesma-Martinez et al. 2016).
A number of studies showed that HDPSCs is a small
population of cells residing in the pulp tissue which
exhibits a highly proliferative and multi-lineage
differentiation ability (Cui et al. 2014; Gronthos
et al. 2000; Mortada and Mortada 2018). These cells
are thought to play a role in the repair of damaged pulp
and dentine by differentiating into specialised cells—
odontoblasts secreting dentine matrix. Extensive
research has since been carried out pursuant to a good
understanding of HDPSCs and their potential in tissue
engineering (Kawashima and Okiji 2016).
In natural conditions, type I collagen is predomi-
nantly present in the bone extracellular matrix. It not
only provides the substrate for cell attachment and
migration but also influences the osteogenic differen-
tiation of the adhered cells. Thus, there has been an
increasing interest in the application of type I collagen
for bone tissue engineering (Weisgerber et al. 2016).
Structurally, individual type I collagen molecules are
triple helical structures, comprising of two a1 and one
a2 polypeptide chains. Each of these chains contains
approximately 1000 amino acid residues and is twisted
into a right-handed helix. A number of studies have
shown that the exposed half turns of the helical
structure act as cell-binding sites, through which
collagen interacts with cell surface integrin receptors
(Murray et al. 2003; Rodwell and Kennelly 2000; Xu
et al. 2000). As a result, collagen triggers the
signalling pathway to direct the cells in attachment,
migration and osteogenic differentiation (Bhatnagar
et al. 1999b; Emsley et al. 2000). A synthetic analogue
of this cell-binding domain was produced syntheti-
cally to mimic the function of the collagen molecule
under in vitro conditions for osteogenic induction in
cells. This synthetic protein is referred to as ‘‘peptide
15’’ or ‘‘P-15’’ (Bhatnagar et al. 1999b, 1997; Scaria
et al. 1989). The function of P-15 on its own has been
tested on osteoblastic cell lines—MG63 and HBMSCs
(Carinci et al. 2004; Sollazzo et al. 2009). Based on
microarray analysis, osteoblastic cells were observed
to up-regulate fibronectin, cell cycle and signal
transduction related genes after culture in P-15
(Carinci et al. 2004). P-15 peptide under in vitro
conditions was observed to function similar to the
collagen by influencing the up-regulation of bone-
specific proteins in HBMSCs.
123
Cytotechnology
In the case of bone regeneration, it is anticipated
that an ideal bone graft substitute provides all the
essential features of an autologous bone graft, includ-
ing both the organic and inorganic components of the
natural bone. With this concept in mind, a three-
dimensional scaffold material was designed by incor-
porating P-15 peptides on ABM particles, a natural
xenogenic source of hydroxyapatite (HA) (Bhatnagar
et al. 1999b). These bovine bone chips are pre-treated
at high temperatures to remove the organic compo-
nents of the bone, leaving only the inorganic compo-
nents (Bhatnagar et al. 1999b; Hofmann et al. 2007;
Yuan et al. 2007), which is the major inorganic
constituent of natural bone (Neshati et al. 2012).
ABM-P-15 mimics the structural framework of the
autologous bone graft by supplying both the cell-
binding domain of type I collagen and HA for the
growth of the cells. To date, ABM-P-15 scaffolds have
been successfully tested on both animal models and on
humans (Emecen et al. 2009), which demonstrated
that P-15 adsorbed on ABM scaffolds enhanced
attachment, growth and osteogenic differentiation of
the tested cells when compared with ABM scaffolds
alone. By far, extensive work has been carried out on
the application of ABM-P-15 scaffolds on its own and
using different cell types for bone tissue engineering
application (Barboza et al. 2002; Lindley et al. 2010;
Mardas et al. 2008; Matos et al. 2011; Sarahrudi et al.
2008; Scarano et al. 2003; Thorwarth et al. 2005;
Vastardis et al. 2005; Yang et al. 2004). The aim of this
study was to compare the osteogenic potential of
HDPSCs with HBMSCs and the effect of P-15 on the
bone-forming capacity of HDPSCs in vitro and in vivo
for the potential of combining these two to improve the
bone regeneration efficacy in the clinical setting.
Materials and methods
Tissue culture reagents were obtained from Corning
Life Sciences B.V. (The Netherlands). Alpha-modi-
fied minimal essential media (a-MEM) without L-
glutamine was purchased from Lonza (UK) and fetal
bovine serum (FBS) was from Biosera (UK). Molec-
ular biology reagents were purchased from Invitrogen
(UK). Dexamethasone, alkaline phosphatase kits, and
all other biochemical reagents were of analytical grade
from Sigma (UK) unless otherwise stated.
Scaffold synthesis and preparation
Two types of scaffolds were used in this study:
anorganic bovine mineral (Osteo-Graf/N-300)
absorbed with/without P-15, which are FDA approved
for the dental application and are commercially
available as PepGen P-15 (Cerapedics, Inc. CO,
USA). The particles are described in our previous
paper (Yang et al. 2004). The 48 well tissue culture
plates were coated with 12% poly(2-hydroxyethyl
methacrylate)(Poly Sciences, PA) to prevent cell
attachment to the plastic. 35 mg of ABM-P-15 or
ABM particles were transferred into the well and
sterilised using UV radiations for 30 min.
Isolation and culture of HDPSCs and HBMSCs
Sound third molar teeth were extracted at Leeds
School of Dentistry with patients’ informed consent
and ethical approval (LREC 07/H1306/93). A total of
20 human teeth was collected (average age:
24 ± 4 years). HDPSCs were isolated and in vitro
expanded as previously described (El-Gendy et al.
2013, 2015; Gronthos et al. 2000; Ricordi et al. 1992).
4 human bone marrow samples (average age:
59 ± 16 years) were obtained from routine total hip
replacement patients at Leeds General Infirmary and
Chapel Allerton Hospital with patients’ informed
consent ethical approval by the NHS local ethical
committee (COREC: 06/Q1206/165). HBMSCs were
isolated and in vitro expanded as previously described
(Yang et al. 2001). HDPSCs and HBMSCs were
seeded at 2 9 105 cells/well on 35 mg ABM-P-15
and/or ABM particles and were cultured in 500 lL of
basal media (a-MEM supplemented with 10% FBS,
1% penicillin/streptomycin, 2 mM L-glutamine) in an
incubator (Binder, Germany) at 37 C with 5% CO2.
Multi-lineage inductive culture of HDPSCs
and HBMSCs
For osteogenic culture, HDPSCs and HBMSCs were
seeded in 24 well plates (2 9 104 cells/well, P3,
n = 3) and cultured for 3 weeks at 37 C, 5% CO2 in
osteogenic media (basal media supplemented with
10 nM dexamethasone and 100 lM L-ascorbic acid
2-phosphate). Basal medium alone was used as the
controls for both cell groups. The media were changed
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every 5 days until the cells were harvested for alkaline
phosphatase staining.
For adipogenic culture, hDPSCs were seeded onto
24 well plates (2 9 104 cells/well, P3, n = 3) and
cultured for 3 weeks at 37 C and 5% CO2 in
adipogenic induction media—basal medium supple-
mented with 1 lM dexamethasone (Sigma), 200 lM
indomethacin, 0.5 mM isobutyl-methyl xanthine
(Sigma) and 10 lg/mL insulin. The basal medium
alone was used as the control. The cells were fixed in
10% neutral buffered formalin (NBF) and were then
stained with 0.6%Oil red O (Sigma) for 15 min for the
identification of lipid droplets.
For chondrogenic culture, HDPSCs and HBMSCs
(5 9 105 cells/mL; P3; n = 3) were cultured as pellets
in the basal media for 48 h before transferring into
chondroinductive media and maintained at 37 C, 5%
CO2 for 3 weeks with media changes every 3 days.
Basal medium alone was used as the control group.
The chondroinductive medium was prepared by
supplementing the basal media with 0.1 lM dexam-
ethasone (Sigma, UK), 10 ng/mL TGF b3, 50 lg/mL
L-ascorbic acid 2-phosphate (Sigma, UK) and 5 lg/
mL insulin transferrin selenium (ITS) (Sigma, UK).
All cell pellets were, paraffin-embedded, sectioned
and stained with Alcian blue/Sirius red for the
detection of GAG and collagenous matrix. HDPSCs/
HBMSCs growth on the ABM-P-15 and/or ABM
scaffold materials was investigated using a confocal
microscope, where a series of X–Y–Z images were
taken through the scaffold particles permitting 3D
reconstruction.
Assessment of cells viability and growth on ABM-
P-15 and ABM scaffolds
At different time points (24 h, 14 days and 6 weeks),
HDPSCs and HBMSCs cultured on ABM-P-15 and
ABM particles were fluorescently labeled with
CellTrackerTM Green (CMFDA). Viable cells were
imaged under an inverted fluorescent microscope or
the Leica confocal microscope (AOBS, UK).
Scanning electron microscopy
After 6 weeks culturing of HDPSCs and HBMSCs on
ABM-P-15 and/or ABM scaffolds, the samples were
vacuum dried for 16 h and sputter-coated with gold
using an E5000 sputter coater (Polaron, UK) to a
thickness of 20 nm prior being imaged under a Hitachi
S-3400 N/Nx scanning electron microscope (Hitachi
High Technologies, Japan).
Alkaline phosphatase staining
After fixation in 98% ethanol, the scaffold constructs
were incubated in a solution containing 400 lL 0.25%
Naphthol AS-MX phosphate (Sigma, UK), 2.4 mg of
Fast Violet salt in 10 mL distilled water at 37 C for
30 min (in darkness). Cells expressing alkaline phos-
phatase enzymes were stained in red colour.
Alkaline phosphatase specific activity (ALPSA)
quantification
ALP was quantified in HDPSCs and HBMSCs
cultured either as monolayers or on 3D ABM-P-15
and/or ABM scaffolds as described previously (Lu
et al. 2014; Yang et al. 2003) using a fluorescence
spectrophotometer (Fluoroskan ascent, Thermo UK)
at 520 nm. Then the ALP activities were normalised to
the relevant total DNA content to get the ALPSAs.
Statistical analysis was carried out using one-way
analysis of variance test with Tukey–Kramer multiple
comparisons test. The software used for statistical
comparison was GraphPad Instant Software (Graph-
Pad Software, Inc., SanDiego).
In vivo implantations
Previously, we have reported that ABM-P-15
enhanced HBMSCs bone formation in vivo compared
to the ABM scaffold alone (Yang et al. 2004). In this
study, we investigated the osteogenic capacity of
HDPSCs on ABM-P-15 particles to explore its poten-
tial for bone tissue engineering under the Home Office
project license (40/2953). Briefly, HDPSCs (130 mL
containing 5 9 106 cells per chamber) were injected
into diffusion chambers (Millipore, Bedford, MA)
containing ABM-P-15 or ABM alone (n = 4), which
were implanted intraperitoneally in MF1 Nu/Nu mice
as previously described (Lu et al. 2014) for up to
8 weeks.
Alcian blue/Sirius red staining
The samples were partially demineralised in 10%
EDTA (pH 7.4) for 2 weeks and embedded in paraffin.
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The sections were stained with Alcian blue (0.5 g in
1% acetic acid in water; Sigma, UK) for 10 min and
then immersed in 1% aqueous phosphomolybdic acid
(Fluka, UK) prior to being stained with 0.3% picrosir-
ius red (Fluka, UK) for an hour.
Immunofluorescence staining
The sections were firstly incubated in primary anti-
bodies including COL1 (1/50, overnight), OCN (1/50,
1 h) and OPN (1/100) which were followed by
incubation for 1 h in FITC-labelled secondary anti-
bodies (goat anti-mouse for COLI, and/or swine anti-
rabbit for OCN). The omit of primary antibody was
used as the negative control. The sections were then
washed in 1 9 PBS with agitation for 2 h and the
nuclei stained with TO-PRO-3 at 1/100 in PBS for
20 min. The images were taken under a confocal
microscope.
Results
Multi-lineage differentiation capacity of HDPSCs
compared to HBMSCs in monolayer culture
After 3 weeks of culture, HDPSCs showed much
stronger ALP positive staining (red colours. Black
arrows) in both osteogenic conditions (Fig. 1a), and
basal medium (Fig. 1b) compared to that of HBMSCs
in the same culture conditions (Fig. 1c & d) respec-
tively. Osteogenic inductive culture enhanced the ALP
staining in both cell groups compared to the same cells
in the basal medium culture. After 3 weeks of culture
in adipogenic inductive media, Oil red O staining
showed that adipogenic culture condition induced
lipid droplet formation in both HDPSCs (Fig. 1e) and
HBMSCs (Fig. 1g) groups compare to the same cells
in basal medium culture condition (Fig. 1f, h) respec-
tively. However, there was no notable difference in
staining between HDPSCs and HBMSCs. After
3 weeks of pellet culture in chondrogenic media, both
HDPSCs (Fig. 1i) and HBMSCs (Fig. 1k) samples
were stained strongly positive for Alcian blue staining
probably reflecting sulphate glycosaminoglycans
(GAGs: blue colours) with the sparse presence of
collagen (red colours) which was indicated when the
pellets were stained up by Sirius red (red colour).
There were some chondrocyte-like cells within the
pellets and somewhere, the chondrocyte-like cells
aligned in column-oriented in certain directions
(Fig. 1i, k and the inserts: black arrows). In compar-
ison, both cells in the basal medium culture condition
appeared to lack of blue staining (Fig. 1j and l).
HDPSCs/HBMSCs viability and spreading
on ABM-P-15 and ABM scaffolds
After 24 h of cell seeding (n = 3), CMFDA fluores-
cent labelling showed that the majority of both cells on
ABM-P-15 and ABM alone are viable. HDPSCs
(Fig. 2a) and HBMSCs (Fig. 2c) were observed to
have more cell attachment and better spreading on the
scaffolds in ABM-P-15 groups in comparison to that
of the ABM alone group (Fig. 2b and d), where the
most of the particles only have a few cells attached.
After 14 days of culture in basal media, HDPSC
showed better cell spreading, and proliferation (cell
density), cell bridging formation on ABM-P-15
(Fig. 2e) compare to HBMSCs on the ABM-P-15
scaffolds (Fig. 2g). Both cells’ growth on ABM alone
was shown in Fig. 2f and h. After 6 weeks in culture
(n = 3) in basal media, Live/dead labelling and
confocal images showed that extensive HDPSCs on
both ABM-P-15 and ABM scaffolds after 6 weeks of
culture (Fig. 2i and j). For both scaffold types,
HDPSCs were seen to be spread across scaffold
particles to form cell bridges. The clustering of the
scaffolds particles was observed in the case of the
ABM-P-15 scaffolds (Fig. 2i) in comparison with the
same cells on ABM scaffolds (Fig. 2j). However,
there was much less HBMSCs growth on both scaffold
types compared to the HDPSCs. Similarly, it can be
seen that P-15 enhanced the growth of HBMSCs on
ABM-P-15 (Fig. 2k) in comparison to the same cells
on the ABM alone scaffolds (Fig. 2l).
SEM imaging to show cells growth and matrix
deposition on ABM-P-15 and ABM scaffolds
After 6 weeks of culture in basal medium, Scanning
electron micrographs showed that HDPSCs and
HBMSCs had formed clusters, presumably related to
cell bridging and matrix deposition on ABM-P-15
(Fig. 3a and c) and ABM scaffolds (Fig. 3b and d).
The cells on the scaffolds appeared to have formed a
thick sheet-like layer encasing the scaffold particles.
This was observed for both cell types and for ABM-P-
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15 and ABM alone scaffolds, respectively. Figure 3e
and f showed the ABM-P-15 and ABM scaffolds
without cells.
ALP staining and ALP Specific activity
of HDPSCs and HBMSCs on ABM-P-15 and/
or ABM particles
After 6 weeks of culture in basal medium, ABM-P-15
groups for both HDPSCs and HBMSCs showed
enhanced ALP staining compared to that of the same
cell types on ABM scaffolds (Fig. 4). There was no
visible difference between HDPSCs (Fig. 4a) and
HBMSCs groups on the ABM-P-15 scaffolds
(Fig. 4c). For the ABM alone groups, the HBMSCs
group (Fig. 4d) showed stronger ALP stain than that of
the HDPSCs group (Fig. 4b). However, these were not
a significant difference in the ALPSA (P[ 0.05).
Biochemical quantitative assays confirmed that
HDPSCs cultured on ABM-P-15 scaffolds had the
highest ALPSA compared to HDPSCs on ABM alone
scaffolds (200% increase) (P\ 0.001, Fig. 4e).
Similarly, HBMSCs cultured on ABM-P-15 scaffolds
also had significantly higher ALPSA compared to the
cells cultured on ABM scaffolds alone (100%
increase) (P\ 0.05, Fig. 4e). The mean of ALPSA
of HDPSCs was 30% higher than that of HBMSCs on
the ABM-P-15 group. However, there was no statistic
difference in the ALPSA between the two cell types
(P[ 0.05).
Sirius red staining and Birefringence images
to show the fibrous collagen matrix present
in HDPSC-ABM-P-15 and/or ABM scaffold
construct in vivo
After 8 weeks of in vivo implantation (n = 4), three
out of four HDPSCs-ABM-P-15 constructs showed
positive staining for Sirius red (Fig. 5a). In compar-
ison, only one out of four HDPSCs-ABM constructs
showed positive stinging for Sirius red (Fig. 5b). In the
negative control groups, ABM-P-15 and ABM scaf-
folds without cells, there was no indication of the
presence of cells or tissues within the constructs.
Fig. 1 Histological staining of HDPSCs (a, b, e, f, i, j) and
HBMSCs (c, d, g, h, k, l) after 3 weeks of culture under
osteogenic (a, c), adipogenic (e, g), chondrogenic (i,
k) inductions and basal conditions (b, d, f, h, j, l). a–d ALP
staining; e–h Oil red O staining; i–l) Alcian Blue/Sirius red
staining. Scale bars-100 lm
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Under polarized light microscopy, the Sirius red-
stained collagen matrix exhibited birefringence, and
the fibres appeared green/red/orange in colour (Fig. 5c
and d). A denser and more highly organised collagen
matrix was observed in the HDPSCs-ABM-P-15
constructs (Fig. 5c) compared to that in the
HDPSCs-ABM constructs (Fig. 5d).
Immuno fluorescent characterisation
of the extracellular matrix of HDPSCs-ABM-P-15
and/or HDPSCs-ABM scaffolds constructs in vivo
After 8 weeks of in vivo implantation, immunofluo-
rescent staining showed that HDPSCs-ABM-P-15
groups appeared to have more and stronger positive
stains (green colour, red arrows) for COL1 and OCN
within the cells and extracellular matrixes, the
collagen matrixes were dense and organised around
individual ABM-P-15 scaffold (Fig. 6a and b) com-
pared to that of ABM alone group (Fig. 6e and f)
respectively, in which the matrixes were less organ-
ised between the scaffold particles while the most of
organised matrixes were observed around the periph-
eral layer. In comparison, there were less staining for
OCN than COL1 within the same group. The nuclei
were stained as blue colour, and the ABM particles
were shown as the grey colour (blue arrows). The
HDPSCs on both ABM-P-15 (Fig. 6c) and ABM
scaffold groups showed strong positive stains for OPN
(Fig. 6g). There was no clear difference between the
two groups. There were not positive stains in the
negative control groups (without primary antibodies)
on ABM-P-15 (Fig. 6d) and ABM alone (Fig. 6h).
Fig. 2 Fluorescent micrographs from an inverted fluorescent
microscope (a–h) and confocal microscope (i–l) of CMFDA
labelled HDPSCs (a, b, e, f, i, j) and HBMSCs (c, d, g, h, k,
l) after 24 h (a–d), 4 days (e–h) and 6 weeks (i–l) of in vitro
cultures on ABM-P-15 (a, e, i, c, g, k) and ABM scaffolds (b, f,
j, d, h, l) (n = 3). Red arrows: viable cells; blue arrows: ABM-P-
15/ABM particle. Magnifications: 9100
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Discussion
Translational research on bone tissue engineering
aims to develop cell-based bone graft material that
could be employed as a substitute for the traditional
grafts for bone augmentation. However, one of the
current challenges in this field is the identification of
an ideal combination of stem cells, scaffold material
and growth factors that could be used for faster repair/
regeneration of damaged bone (Panetta et al. 2009)
and/or improve the implant-bone osseointegration
(Jayesh and Dhinakarsamy 2015; Ting et al. 2016).
In this study, the effect of ABM-P-15 on HDPSCs
osteogenesis was investigated both in vitro and in vivo
compared with HBMSCs with the aims of developing
novel stem cell-biomaterials combinations for enhanc-
ing bone tissue repair/regeneration efficacy and
improve the implant-bone interface for clinical
application.
Although HBMSCs has been considered as one of
the most popular stem cell sources (Squillaro et al.
2016; Yoshii et al. 2009), however, due to the
limitation of getting a good quality of HBMSC and
considerable very long doubling time of this cell
population, resulting in a slow or low efficacy bone
formation procedure. In fact, for clinical therapy, the
speed for bone formation may be more important than
the amount of bone formation itself (e.g. taking longer
Fig. 3 Scanning electron
microscopy images of
HDPSCs (a, b) and
HBMSCs (c, b) after
6 weeks of in vitro culture
on ABM-P-15 (a, c) and
ABM (b, d), as well as both
scaffolds without cells (e, f).
HDPSCs and HBMSCs on
both ABM -P-15 and ABM
scaffolds were observed to
deposit matrix (red arrows)
around the scaffolds
particles (blue arrows)
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Fig. 4 ALP staining (a–d) and quantification of ALP specific activities (e) for HDPSCs (a, b) and HBMSCs (c, d) after 6 weeks of
culture on ABM-P-15 (a, c) and ABM (b, d) scaffolds (n = 3). *P\ 0.05; ***P\ 0.001
Fig. 5 Alcian blue/Sirius red staining (a, b) and birefringence
(c, d) of the fibrous collagenous matrix present in HDPSC-
ABM-P-15 (a, c) and/or HDPSC-ABM (b, d) scaffold con-
structs after 8 weeks of in vivo implantation in a diffusion
chamber model. Yellow arrows: collagen matrix formation (red
or bright colour) and orientation; Blue arrows: ABM particles.
Magnifications: 9200
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time). Therefore, researchers are looking for different
alternatives for bone tissue regeneration. A number of
studies showed that HDPSCs from dental pulp tissue is
highly proliferative, short doubling time, multipo-
tency, in particular with high osteogenic potential,
which makes these cells alternative candidates for
bone tissue regeneration (El-Gendy et al. 2015;
Yamada et al. 2019). In this study, both HDPSCs
and HBMSCs showed low adipogenic and chondro-
genic potential but with some osteogenic potential in
basal medium culture conditions. However, when
cultured in inductive media, both HDPSCs and
HBMSCs showed the enhanced capacity for their
osteogenesis, adipogenesis, and chondrogenesis.
HDPSCs group showed stronger stain for Alcian blue,
which indicated more cartilage proteoglycans (Saha
et al. 2013; Ullah et al. 2012) were formed in this
group compared to that of HBMSCs group in basal.
Similarly, the HDPSCs group showed stronger ALP
positive staining than that of HBMSCs group in
osteogenic inductive culture condition. These results
were in agreement with the literature in supporting
HDPSCs as an alternative stem cell source for bone
tissue engineering (El-Gendy et al. 2013; El-Gendy
et al. 2015).
Although in this study, the difference in the number
of cells attached on both ABM scaffolds was not
quantified, morphological observations appeared that
P-15 increased the cell-binding after 24 h of seeding
and enhanced the cell proliferation/cell bridge forma-
tions after 14 days of seeding for both HDPSCs and
HBMSCs onto ABM-P-15 particles compared to
ABM scaffolds alone, which was consistent with our
previous study on HBMSCs (Yang et al. 2004) and the
work of others on different cell populations (Bhatna-
gar et al. 1999b; Emecen et al. 2009; Lallier et al.
2003). Following long term culture (6 weeks in the
basal medium in vitro), interestingly it was observed
that extensive viable HDPSCs were growing on both
ABM-P-15 and ABM alone scaffolds. In comparison,
there were much fewer HBMSCs on both groups
although there was a sign of more HBMSCs on the
ABM-P-15 scaffolds than that on ABM alone scaf-
folds. These may be due to the higher proliferation rate
and lower population doubling time for HDPSCs
(Eslaminejad et al. 2010; Pisciotta et al. 2015)
compared to that of HBMSCs. Bhatnagar et al.
(Bhatnagar et al. 1999c) showed that P-15 stimulated
ECM synthesis. In this study, both HDPSCs or
HBMSCs cultured on ABM-P-15 appeared to deposit
well organised ECM around the individual scaffold
particles after 14 days of seeding, which holds the
separate ABM particles together in clusters (Yang
et al. 2004). In contrast, the cells on ABM alone were
observed to be concentrated on individual scaffold
particles and formed fewer cell bridges with the
neighbouring scaffold particles. The enhanced cell
bridge formation in cells cultured on ABM-P-15might
be attributed to the development of traditional force by
the cells, which is important for the organisation of the
matrix and tissue morphogenesis (Bhatnagar et al.
1999a; Schwartz 2010). This study, however, has not
measured difference in the tractional force imparted
by the cells cultured in the presence of ABM-P-15 and
ABM scaffolds and also no characterisation of the
deposited matrix by HDPSCs/HBMSCs on ABM-P-
15 and ABM scaffolds.
P-15 functions as surrogate collagen in enhancing
osteogenic differentiation of the adhered cells, by the
up-regulation in growth factors expression such as
bone morphogenetic proteins (BMPs)-2, 6 and 7.
Enhanced expression of BMP-2, 6 and 7 are docu-
mented in influencing the cells’ osteogenic differen-
tiation in an autocrine or paracrine manner
(Bandyopadhyay et al. 2006; Li and Cao 2006;
Nguyen et al. 2003) and are involved in the synthesis
of collagen, OCN and other extracellular matrix
proteins (Bhatnagar et al. 1999a, b; Locklin et al.
1999; Warren et al. 2001). ALP is a widely studied
pre-osteoblastic marker that is expressed during the
end of osteoblast proliferation (Lian and Stein 1995;
Lu et al. 2014; Mendes et al. 2004). Immobilised P-15
on ABM scaffolds were observed to up-regulate the
ALP expression of human dermal fibroblasts,
HBMSCs and periodontal ligament fibroblasts (Qian
and Bhatnagar 1996; Yang et al. 2004; Yuan et al.
2007) and this effect has been correlated with the
increase in BMP-2 expression (Spinella-Jaegle et al.
2001). The up-regulation of ALP is essential for
matrix mineralisation as it catalyses the hydrolysis of
phosphomonoesters at alkaline pH (Bellows et al.
1991; Gillette and Nielsen-Preiss 2004). In this study,
both HDPSCs and HBMSCs group showed much
stronger ALP positive staining compared to the same
cell types growth on the ABM scaffold alone after
6 weeks of in vitro culture in basal medium. Quanti-
tative biochemical assays confirmed that the ALPSA
of HDPSCs on ABM-P-15 group is 200% increase
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compared with that of the same cells on ABM along
group. There were 100% increasing in ALPSA in
HBMSCs cultured on ABM-P-15 group than that of
the same cells on ABM alone group. The ALPSA of
HDPSCs on ABM-P-15 group was higher than that of
HBMSCs on ABM-P-15 group (32%), which was
similar to the results of Kwon et al. (2015) (Kwon et al.
2015). These results may indicate that the response of
tested HDPSCs to ABM-P-15 was more sensitive than
the tested HBMSCs. However, there was no statistic
difference in the ALPSA between the two cell types
(P[ 0.05).
The diffusion chamber model has been used for
decades to test the tissue regenerative strategy (Ashton
et al. 1980; Gundle et al. 1995; Howard et al. 2002;
Nawata et al. 2005; Partridge et al. 2002; Yang et al.
2003, 2004). It can be implanted intraperitoneally in
mouse or rat and provide a permissive physiological
environment in supporting stem cell growth, function
and tissue regeneration in vivo. The enclosed system
allows the exchange of nutrients, oxygen and waste
across the membrane filters but prevents the entry of
host cells and tissue into the constructs (Horner et al.
2008; Lu et al. 2014). Previously, we have shown that
ABM-P-15 promoted HBMSCs forming bone matrix
after 6 weeks implantation (Yang et al. 2004). Sim-
ilarly in this study, after 8 weeks in vivo implantation
in MF1 Nu/Nu mice, the ABM-P-15 group showed
highly organised collagen matrix formation within the
diffusion chamber, which indicates that ABM-P-15
enhanced HDPSC bone formation compared to that of
ABM alone group. These results were supported by
enhanced immune fluorescent staining for COL-1 and
OCN, in the ABM-P-15 group, confirming terminal
differentiation of the HDPSCs. In comparison to the
normal light microscope, the use of polarised micro-
scopy for the identification of collagen orientation is
preferred as it increases the specificity and resolution
for the observation of the thin collagen fibres which
are not detectable under normal microscopy (Jun-
queira et al. 1979; Rich and Whittaker 2005; Spiesz
et al. 2011; Traini et al. 2006).
In the native microenvironment, the cells are under
constant interaction with the extracellular matrix
through the integrin receptors present in the cell
membrane (De Franceschi et al. 2015; Schwartz
2010). Integrin receptors, not only function as cell
adhesion molecules for the anchorage of the cells to
the matrix but are also involved in the transmission of
bidirectional signals across the cell, and the matrix
thereby helps in the regulation of the cell proliferation,
migration and differentiation (Carinci et al. 2004;
Emsley et al. 2000; Jokinen et al. 2004). Similar to the
native collagen fibre, the P-15 receptors have also
been identified to interact with the a2b1 integrin
receptors of the cells to enhance the attachment and
differentiation in different cell types. The biomimetic
scaffolds employed in this study mimics the autolo-
gous bone structure, where the surfaces of ABM
particles are immobilised with P-15 peptides, which
are molecules of the cell recognition sequence of the
type 1 collagen (Bhatnagar et al. 1998; Murray et al.
2003; Pountos et al. 2016; Xu et al. 2000; Yu et al.
2011) and can initiate the cascade events for bone
formation. A number of studies have also shown that
ABM-P-15 enhances osteogenic differentiation and
bone matrix formation using different cell types
(Lindley et al. 2010; Matos et al. 2011; Vastardis
et al. 2005; Yang et al. 2004; Yuan et al. 2007). The
combination of ABM with P-15 and autologous
HDPSCs is to mimic autologous bone graft.
Conclusion
The current study provided direct evidence that
HDPSCs contain multipotent stem cells that have a
high proliferation rate and osteogenic potential com-
pared to HBMSCs. ABM-P-15 promoted HDPSCs
osteogenic differentiation and bone matrix formation
both in vitro and in vivo, which indicated the potential
of combining HDPSC and ABM-P15 for enhancing
bone tissue engineering efficacy to meet the clinical
reality in tackling fracture non-union, critical bone
defect and/or implant loosening in orthopaedics and
dentistry.
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